The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
The scientists believe this information could help unravel drug modes of action and potentially help doctors tailor treatments based on patient proteomic profiles.
Medulloblastoma Long-Read Sequences Reveal Complex Rearrangements, Methylation Changes
With Oxford Nanopore sequencing, researchers found DNA methylation clues and complex rearrangement patterns that were subsequently assessed in a broader cancer set.
Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study
The companies will apply Pangea's ENLIGHT platform to map gene interactions in pathways modulated by Onconova's investigational cancer therapy rigosertib.
Baylor Team Aims to Identify Chemo Toxicity Biomarkers in Latino Pediatric Leukemia Patients
The CPRIT-funded study will examine clinical and genomic data from more than 2,000 Latino patients with acute lymphoblastic leukemia treated with high-dose chemo.
BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy
Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.